| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.9727 | 
      | Human Intestinal Absorption | HIA+ | 1.0000 | 
      | Caco-2 Permeability | Caco2+ | 0.8654 | 
      | P-glycoprotein Substrate | Substrate | 0.5901 | 
      | P-glycoprotein Inhibitor | Inhibitor | 0.5668 | 
                                                     | Non-inhibitor | 0.6612 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.7086 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.7226 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8066 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8711 | 
      | CYP450 3A4 Substrate | Substrate | 0.7939 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.7489 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.8774 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9540 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.6545 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.8094 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8393 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8667 | 
                                                                    | Non-inhibitor | 0.7555 | 
      | AMES Toxicity | Non AMES toxic | 0.9567 | 
      | Carcinogens | Non-carcinogens | 0.9316 | 
      | Fish Toxicity | High FHMT | 0.9792 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9690 | 
      | Honey Bee Toxicity | High HBT | 0.8651 | 
      | Biodegradation | Not ready biodegradable | 0.9529 | 
      | Acute Oral Toxicity | III | 0.7929 | 
      | Carcinogenicity (Three-class) | Warning | 0.4754 |